Robert E. Pollack
Corporate Officer/Principal bij The Trustees of Columbia University in The City of New York
Profiel
Robert E.
Pollack is a Professor at The Trustees of Columbia University in The City of New York.
He was previously a Director at Tapestry Pharmaceuticals, Inc., NXXI, Inc., and Mirabilis Ventures, Inc.
Actieve functies van Robert E. Pollack
| Bedrijven | Functie | Begin |
|---|---|---|
| The Trustees of Columbia University in The City of New York | Corporate Officer/Principal | - |
Eerdere bekende functies van Robert E. Pollack
| Bedrijven | Functie | Einde |
|---|---|---|
Mirabilis Ventures, Inc.
 Mirabilis Ventures, Inc. Investment ManagersFinance Mirabilis Ventures, Inc. is a private equity fund based in Orlando, Florida. | Directeur/Bestuurslid | 28-05-2008 |
Tapestry Pharmaceuticals, Inc.
 Tapestry Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tapestry Pharmaceuticals, Inc. develops, manufactures, and markets an anti-cancer pharmaceutical called Paclitaxel. It focuses on the development of proprietary therapies for the treatment of cancer, new products and technologies may involve the examination of individual molecules and classes of compounds. The company was founded in 1991 and is headquartered in Ankeny, IA. | Directeur/Bestuurslid | 05-02-2008 |
NXXI, Inc.
 NXXI, Inc. Pharmaceuticals: MajorHealth Technology NXXI, Inc. operates as a nutritional bioscience company. It primarily develops and markets raw materials, formulations, compounds, blends and bulk and other materials to third-party non-end users to be further fabricated, blended or packaged for ultimate sales to end-users as nutritional supplements. The company was founded on June 29, 1983 and is headquartered in Purchase, NY. | Directeur/Bestuurslid | 07-04-2005 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
NXXI, Inc.
NXXI, Inc. Pharmaceuticals: MajorHealth Technology NXXI, Inc. operates as a nutritional bioscience company. It primarily develops and markets raw materials, formulations, compounds, blends and bulk and other materials to third-party non-end users to be further fabricated, blended or packaged for ultimate sales to end-users as nutritional supplements. The company was founded on June 29, 1983 and is headquartered in Purchase, NY. | Health Technology |
Mirabilis Ventures, Inc.
Mirabilis Ventures, Inc. Investment ManagersFinance Mirabilis Ventures, Inc. is a private equity fund based in Orlando, Florida. | Finance |
Tapestry Pharmaceuticals, Inc.
Tapestry Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tapestry Pharmaceuticals, Inc. develops, manufactures, and markets an anti-cancer pharmaceutical called Paclitaxel. It focuses on the development of proprietary therapies for the treatment of cancer, new products and technologies may involve the examination of individual molecules and classes of compounds. The company was founded in 1991 and is headquartered in Ankeny, IA. | Health Technology |
